The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

This morning, at the annual Education & Training Awards breakfast, the NYC Building & Construction Industry Safety Fund ...

Twenty years ago, in 2004, Congress passed the Project BioShield Act, which established the Biomedical Advanced Research and ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

At the end of last year, the Mobile County Health Department’s (MCHD) Overdose Prevention Program worked with LTS Health on a project to supply four healthcare ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Community collaboration, harm reduction models and policy changes can ease the burden on EMS workers and improve patient outcomes ...

China has reported two more H9N2 avian flu infections in humans, both of them patients from Hunan province in the southern ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.